期刊文献+

常染色体显性多囊肾病患者与正常成人尿液的定量比较蛋白质组学分析 被引量:4

Comparative proteomic analysis of urine from autosomal dominant polycystic kidney disease patients and normal adults
原文传递
导出
摘要 目的搜索常染色体显性多囊肾病(ADPKD)患者与正常成人尿液蛋白质组中有丰度差异的蛋白质成分。方法制备ADPKD患者(PKD1突变)及正常成人尿液蛋白组样品,同位素编码的亲和力标签法标记蛋白质、筛选被标记肽段,二维液相色谱-串联质谱法分离鉴定被标记肽段,从而鉴定蛋白质。通过计算两同位素试剂标记的相同肽段指纹峰面积比,寻找有丰度差异的蛋白质。根据被鉴定肽段的可信度,从鉴定出的蛋白质中选出6种,免疫印迹法验证其在两尿液蛋白组样品中的丰度差异。结果两尿液蛋白质组共鉴定出尿蛋白质106种, ADPKD患者尿液中水平较正常上调者48种,下调者45种。其中多囊蛋白1、肝细胞生长因子、单核细胞趋化蛋白3及孕激素受体等5种蛋白丰度差异为免疫印迹所证实。结论包括多囊蛋白1在内的多种蛋白质成分在ADPKD患者尿液中丰度发生改变,差异蛋白包括生长因子、凋亡调节蛋白、细胞外基质成分、受体、参与胞浆运输的蛋白质、酶类、细胞信号蛋白、转录因子及转录调节因子等,这些蛋白质信息可能为寻找与ADPKD发病相关的蛋白提供部分实验依据。 Objective To identify proteins which have different abundance in the proteomes of patients with autosomal dominant polycystic kidney disease (ADPKD) and normal adults. Method Urine proteomes of ADPKD patients (PKD1 mutated) and normal adults were labeled on cysteine residues respectively with isotope-coded affinity tag (ICAT) heavy (13C) reagent and light (12C) reagent, and then mixed and digested by trypsin. The labeled cysteine-containing peplides were purified by affinity chromatography. They were separated and analyzed by two dimensional liquid chromatography-tandem mass spectrometry (2D LC-MS/MS) for protein identification and quantification. According to the confidence of their peptides, abundance differentiation of 6 identified proteins were selected and were tested by Western blot.Results One hundred and six proteins were identified from two resources of urine proteomes. Among them, 48 were up-regulated with 45 down-regulated in ADPKD patients. Abundance differentiation of 5 identified proteins (polycystin-1, hepatocyte growth factor, monocyte chemotactic protein 3, progesterone receptor and retinoblastoma-like protein 2) among the 6 types were verified by Western blot. Conclusion Urine proteins differ in abundance between ADPKD patients and normal adults, including polycystin-1, growth factors, apoptosis regulators, matrix proteins, receptors, transporters, enzymes, cell signaling proteins, transcription factors and regulators, and so on. Data of this study may provide, at least partly, valuable experimental evidence of proteins involved in the pathogenesis of ADPKD.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2005年第6期345-350,共6页 Chinese Journal of Nephrology
  • 相关文献

参考文献8

  • 1Regnier FE, Riggs L, Zhang R, et al. Comparative proteomics based on stable isotope labeling and affinity selection. J Mass Spetrom, 2002, 37: 133-145.
  • 2赵海丹,梅长林,沈学飞,孙田美,张树忠,王文靖,吴玉梅,宋吉.多囊蛋白-1 LRR-WSC区单克隆抗体的制备及其在免疫组织化学诊断中的应用[J].中华检验医学杂志,2004,27(8):518-522. 被引量:4
  • 3Hancock WS. Contribution of ion trap mass spectrometers to proteomics. Int Lab, 2001,31: 29-31.
  • 4Mengerink K J, Moy GW, Vacquier VD. suREJ3, a polycystin-1 protein, is cleaved at the GPS domain and localizes to the acrosomal region of sea urchin sperm. J Biol Chem, 2002,277: 943-948.
  • 5Qian F, Boletta A, Bhunia AK, et al. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc Natl Acad Sci USA, 2002, 99:16981-16986.
  • 6Wilson PD. Polycystic kidney disease. N Engl J Med, 2004,350: 151-164.
  • 7Nichols MT, Gidey E, Matzakos T, et al. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology, 2004,40: 836-846.
  • 8Horie S, Higashihara E, Nutahara K, et al. Mediation of renal cyst formation by hepatocyte growth factor. Lancet,1994,344: 789-791.

二级参考文献12

  • 1Lakkis M,Zhou J.Molecular complexes formed with polycystins.Nephron Exp Nephrol,2003,93: e3-8.
  • 2Murcia NS,Sweeney WE Jr,Avner ED.New insights into the molecular pathophysiology of polycystic kidney disease.Kidney Int,1999,55: 1187-1197.
  • 3Igarashi P ,Somlo S.Genetics and pathogenesis of polycystic kidney disease.J Am Soc Nephrol,2002,13: 2384-2398.
  • 4Grantham JJ.Polycystic kidney disease: from the bedside to the gene and back.Curr Opin Nephrol Hyperten,2001,10: 533-542.
  • 5Wilson PD.Polycystin: new aspects of structure,function,and regulation.J Am Soc Nephrol,2001,12: 834-845.
  • 6Ong AC,Harris PC,Davies DR,et al.Polycystin-1 expression in PKD1,early-onset PKD1,and TSC2/PKD1 cystic tissue.Kidney Int,1999,56: 1324-1333.
  • 7Geng L,Segal Y,Peissel B,et al.Identification and localization of polycystin,the PKD1 gene product.J Clin Invest,1996,98: 2674-2682.
  • 8Palsson R,Sharma CP,Kim K,et al.Characterization and cell distribution of polycystin,the product of autosomal dominant polycystic kidney disease gene 1.Mol Med,1996,2: 702-711.
  • 9Ward CJ,Turley H,Ong AC,et al.Polycystin,the polycystic kidney disease 1 protein,is expressed by epithelial cells in fetal,adult,and polycystic kidney.Proc Natl Acad Sci U S A,1996,93: 1524-1528.
  • 10Ong AC,Ward CJ,Bucler RJ,et al.Coordinate expression of the autosomal dominant polycystic kidney disease proteins,polycystin-2 and polycystin-1,in normal and cystic tissue.Am J Pathol,1999,154: 1721-1739.

共引文献3

同被引文献41

  • 1吴登龙,张元芳,关明,刘薇薇,徐月敏,金三宝,金重睿,张炯,吕元.蛋白质芯片技术筛选膀胱癌尿液标记物的研究[J].中华泌尿外科杂志,2004,25(7):453-455. 被引量:16
  • 2金世辉,刘必成,唐祖明.抗体蛋白质芯片及其在医学中的应用近况[J].东南大学学报(医学版),2004,23(5):340-343. 被引量:4
  • 3金世辉,刘必成,唐祖明,陆祖宏.蛋白质微阵列载体的选择及表面修饰方法[J].国外医学(生物医学工程分册),2005,28(4):209-213. 被引量:5
  • 4高红军,孙玉琳,赵晓航.细胞培养稳定同位素标记技术与肿瘤标志分子研究[J].基础医学与临床,2007,27(2):113-121. 被引量:4
  • 5Decramer S, Gonzalez-de-Peredo A, Breuil B, et al. Urine in clinical proteomics[J]. Mol Cell Proteomics, 2008, 7(10) : 1850- 1862.
  • 6Chromy B A, Gonzales A D, Perkins J, et al. Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins[ J ]. J Proteome Res, 2004, 3 (6) : 1120- 1127.
  • 7Tantipaiboonwong P, Sinchaikul S, Sriyam S, et al. Different techniques for urinary protein analysis of normal and lung cancer patients [ J ]. Proteomics, 2005, 5 (4) : 1140 - 1149.
  • 8Meier M, Kaiser T, Hemnann A, et al. Identification of urinary protein pattern in Type I diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis [ J ]. J Diabetes Complications, 2005, 19(4) : 223 -232.
  • 9Vlahou A, Sehellhammer P F, Mendrinos S, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine[J]. Am J Pathol, 2001, 158(4): 1491 - 1502.
  • 10Schaub S, Wilkins J A, Antonovici M, et al. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts[ J]. Am J Transplant, 2005, 5 (4 Pt 1 ) : 729 -738.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部